Subscribe to RSS
DOI: 10.1055/s-0044-1796639
Predicting Renal Cell Carcinoma Subtypes and Fuhrman Grading Using Multiphasic CT-Based Texture Analysis and Machine Learning Techniques
Funding None.Abstract
Objectives The aim of this study is to evaluate computed tomography texture analysis (CTTA) on multiphase CT scans for distinguishing clear cell renal cell carcinoma (ccRCC) from non-ccRCC and predicting Fuhrman's grade in ccRCC using open-source Python libraries.
Methods Conducted retrospectively, the study included 144 patients with RCCs (108 ccRCCs and 36 non-ccRCCs) who underwent preoperative multiphasic CT. Ninety ccRCCs were categorized into 71 low-grade and 19 high-grade ccRCCs. Tumor was marked on the largest axial tumor slice using “LabelMe” across different CT phases. First- and second-order texture features were computed using Python's scipy, numpy, and opencv libraries. Multivariable logistic regression analysis and machine learning (ML) models were used to evaluate CTTA parameters from different CT phases for RCC classification. The best ML model for distinguishing ccRCC and non-ccRCC was externally validated using data from the 2019 Kidney and Kidney Tumor Segmentation Challenge.
Results Entropy in the corticomedullary (CM) phase was the best individual parameter for distinguishing ccRCC from non-ccRCC with (F1 score: 0.83). The support vector machine (SVM) based ML model, incorporating CM phase features, performed the best, with an F1 score of 0.87. External validation for the same model yielded an accuracy of 0.82 and an F1 score of 0.81. ML models and individual texture parameters showed less accuracy for classifying low- versus high-grade ccRCCs, with a maximum F1 score of 0.76 for the CM phase SVM model. Other CT phases yielded inferior results for both classification tasks.
Conclusion CTTA employing open-source Python tools is a viable tool for differentiating ccRCCs from non-ccRCCs and predicting ccRCC grade.
Ethical Approval
Ethical approval was obtained from the institutional review board. The need for patient consent was waived off by the institutional review board due to the retrospective nature of the analysis.
Publication History
Article published online:
11 December 2024
© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol 2016; 70 (01) 93-105
- 2 Capitanio U, Cloutier V, Zini L. et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int 2009; 103 (11) 1496-1500
- 3 Patard JJ, Leray E, Rioux-Leclercq N. et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23 (12) 2763-2771
- 4 Lee CH, Motzer R. Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma. Br J Cancer 2018; 119 (08) 911-912
- 5 Atkins MB, Tannir NM. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat Rev 2018; 70: 127-137
- 6 Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6 (07) 655-663
- 7 Ljungberg B, Albiges L, Abu-Ghanem Y. et al. European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 update. Eur Urol 2019; 75 (05) 799-810
- 8 Abel EJ, Carrasco A, Culp SH. et al. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int 2012; 110 (11) 1742-1746
- 9 Abel EJ, Culp SH, Matin SF. et al. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol 2010; 184 (05) 1877-1881
- 10 Egbert ND, Caoili EM, Cohan RH. et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol 2013; 201 (02) 347-355
- 11 Karlo CA, Di Paolo PL, Chaim J. et al. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 2014; 270 (02) 464-471
- 12 Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 2013; 267 (02) 444-453
- 13 Wang P, Pei X, Yin XP. et al. Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas. Sci Rep 2021; 11 (01) 13729
- 14 Miles KA, Ganeshan B, Hayball MP. CT texture analysis using the filtration-histogram method: what do the measurements mean?. Cancer Imaging 2013; 13 (03) 400-406
- 15 Deng Y, Soule E, Samuel A. et al. CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade. Eur Radiol 2019; 29 (12) 6922-6929
- 16 Ding J, Xing Z, Jiang Z. et al. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. Eur J Radiol 2018; 103: 51-56
- 17 Feng Z, Shen Q, Li Y, Hu Z. CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma. Cancer Imaging 2019; 19 (01) 6
- 18 Budai BK, Stollmayer R, Rónaszéki AD. et al. Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols. Front Med (Lausanne) 2022; 9: 974485
- 19 Kocak B, Yardimci AH, Bektas CT. et al. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation. Eur J Radiol 2018; 107: 149-157
- 20 Han D, Yu Y, Yu N. et al. Prediction models for clear cell renal cell carcinoma ISUP/WHO grade: comparison between CT radiomics and conventional contrast-enhanced CT. Br J Radiol 2020; 93 (1114) 20200131
- 21 Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics 2017; 37 (05) 1483-1503
- 22 Doshi AM, Tong A, Davenport MS. et al. Assessment of renal cell carcinoma by texture analysis in clinical practice: a six-site, six-platform analysis of reliability. AJR Am J Roentgenol 2021; 217 (05) 1132-1140
- 23 Rana M, Bhushan M. Machine learning and deep learning approach for medical image analysis: diagnosis to detection. Multimedia Tools Appl 2022; 1-39
- 24 Russell BC, Torralba A, Murphy KP, Freeman WT. LabelMe: a database and web-based tool for image annotation. Int J Comput Vis 2008; 77 (01) 157-173
- 25 OpenCV. Open Source Computer Vision Library. Accessed November 18, 2024 at: https://opencv.org/
- 26 Tosi S. Matplotlib for Python Developers. Packt; 2023. Accessed October 8, 2024 at: https://www.packtpub.com/product/matplotlib-for-python-developers/9781847197900
- 27 Waskom ML. seaborn: statistical data visualization. J Open Source Softw 2021; 6 (60) 3021
- 28 Hearst MA, Dumais ST, Osman E, Platt J, Scholkopf B. Support vector machines. IEEE Intell Syst Their Appl 1998; 13 (04) 18-28
- 29 Heller N, Sathianathen N, Kalapara A. et al. Data from C4KC-KiTS [Data set]. The Cancer Imaging Archive; 2019 . Accessed October 8, 2024 at: https://doi.org/10.7937/TCIA.2019.IX49E8NX
- 30 Lubner MG, Stabo N, Abel EJ, Del Rio AM, Pickhardt PJ. CT textural analysis of large primary renal cell carcinomas: pretreatment tumor heterogeneity correlates with histologic findings and clinical outcomes. AJR Am J Roentgenol 2016; 207 (01) 96-105